Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Is there an impact of heart exposure on the incidence of radiation pneumonitis? Analysis of data from a large clinical cohort.

Tucker SL, Liao Z, Dinh J, Bian SX, Mohan R, Martel MK, Grosshans DR.

Acta Oncol. 2014 May;53(5):590-6. doi: 10.3109/0284186X.2013.831185. Epub 2013 Aug 30.

PMID:
23992110
2.

Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study.

Rancati T, Ceresoli GL, Gagliardi G, Schipani S, Cattaneo GM.

Radiother Oncol. 2003 Jun;67(3):275-83.

PMID:
12865175
4.

A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.

Claude L, Pérol D, Ginestet C, Falchero L, Arpin D, Vincent M, Martel I, Hominal S, Cordier JF, Carrie C.

Radiother Oncol. 2004 May;71(2):175-81.

PMID:
15110451
5.

Predicting pneumonitis risk: a dosimetric alternative to mean lung dose.

Tucker SL, Mohan R, Liengsawangwong R, Martel MK, Liao Z.

Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):522-7. doi: 10.1016/j.ijrobp.2012.03.052. Epub 2012 May 12.

PMID:
22580121
6.

Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer.

Kim TH, Cho KH, Pyo HR, Lee JS, Zo JI, Lee DH, Lee JM, Kim HY, Hwangbo B, Park SY, Kim JY, Shin KH, Kim DY.

Radiology. 2005 Apr;235(1):208-15. Epub 2005 Feb 9.

PMID:
15703313
7.

Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability.

Seppenwoolde Y, Lebesque JV, de Jaeger K, Belderbos JS, Boersma LJ, Schilstra C, Henning GT, Hayman JA, Martel MK, Ten Haken RK.

Int J Radiat Oncol Biol Phys. 2003 Mar 1;55(3):724-35.

PMID:
12573760
8.

Analysis of related factors associated with radiation pneumonitis in patients with locally advanced non-small-cell lung cancer treated with three-dimensional conformal radiotherapy.

Dang J, Li G, Lu X, Yao L, Zhang S, Yu Z.

J Cancer Res Clin Oncol. 2010 Aug;136(8):1169-78. doi: 10.1007/s00432-010-0764-4. Epub 2010 Feb 4.

PMID:
20130912
9.

Dose-volume factors predicting radiation pneumonitis in patients receiving salvage radiotherapy for postlobectomy locoregional recurrent non-small-cell lung cancer.

Uno T, Isobe K, Kawakami H, Ueno N, Kawata T, Yamamoto S, Sekine Y, Iyoda A, Iizasa T, Fujisawa T, Shigematsu N, Ito H.

Int J Clin Oncol. 2006 Feb;11(1):55-9.

PMID:
16508730
10.

New dose constraint reduces radiation-induced fatal pneumonitis in locally advanced non-small cell lung cancer patients treated with intensity-modulated radiotherapy.

Khalil AA, Hoffmann L, Moeller DS, Farr KP, Knap MM.

Acta Oncol. 2015;54(9):1343-9. doi: 10.3109/0284186X.2015.1061216. Epub 2015 Jul 22.

PMID:
26198657
11.

Lung Size and the Risk of Radiation Pneumonitis.

Briere TM, Krafft S, Liao Z, Martel MK.

Int J Radiat Oncol Biol Phys. 2016 Feb 1;94(2):377-84. doi: 10.1016/j.ijrobp.2015.10.002. Epub 2015 Oct 9.

PMID:
26675062
12.

Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.

De Jaeger K, Seppenwoolde Y, Kampinga HH, Boersma LJ, Belderbos JS, Lebesque JV.

Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1378-87.

PMID:
15050313
13.

Predictive factors for radiation-induced pulmonary toxicity after three-dimensional conformal chemoradiation in locally advanced non-small-cell lung cancer.

Moreno M, Aristu J, Ramos LI, Arbea L, López-Picazo JM, Cambeiro M, Martínez-Monge R.

Clin Transl Oncol. 2007 Sep;9(9):596-602.

PMID:
17921108
14.

Dosimetric factors used for thoracic X-ray radiotherapy are not predictive of the occurrence of radiation pneumonitis after carbon-ion radiotherapy.

Koto M, Tsujii H, Yamamoto N, Nishimura H, Yamada S, Miyamoto T.

Tohoku J Exp Med. 2007 Oct;213(2):149-56.

15.

Heart irradiation as a risk factor for radiation pneumonitis.

Huang EX, Hope AJ, Lindsay PE, Trovo M, El Naqa I, Deasy JO, Bradley JD.

Acta Oncol. 2011 Jan;50(1):51-60. doi: 10.3109/0284186X.2010.521192. Epub 2010 Sep 28.

16.

Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT).

Wang S, Liao Z, Wei X, Liu HH, Tucker SL, Hu CS, Mohan R, Cox JD, Komaki R.

Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1399-407. Epub 2006 Sep 25. Erratum in: Int J Radiat Oncol Biol Phys. 2007 Apr 1;67(5):1606.

PMID:
16997503
17.

[Low dose volume histogram analysis of the lungs in prediction of acute radiation pneumonitis in patients with esophageal cancer treated with three-dimensional conformal radiotherapy].

Shen WB, Zhu SC, Gao HM, Li YM, Liu ZK, Li J, Su JW, Wan J.

Zhonghua Zhong Liu Za Zhi. 2013 Jan;35(1):45-9. doi: 10.3760/cma.j.issn.0253-3766.2013.01.010. Chinese.

PMID:
23648300
18.

Regional differences in lung radiosensitivity after radiotherapy for non-small-cell lung cancer.

Seppenwoolde Y, De Jaeger K, Boersma LJ, Belderbos JS, Lebesque JV.

Int J Radiat Oncol Biol Phys. 2004 Nov 1;60(3):748-58.

PMID:
15465191
19.

Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters.

Hope AJ, Lindsay PE, El Naqa I, Alaly JR, Vicic M, Bradley JD, Deasy JO.

Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):112-24.

PMID:
16618575
20.

Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis.

Kong FM, Hayman JA, Griffith KA, Kalemkerian GP, Arenberg D, Lyons S, Turrisi A, Lichter A, Fraass B, Eisbruch A, Lawrence TS, Ten Haken RK.

Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):1075-86. Epub 2006 May 2.

PMID:
16647222

Supplemental Content

Support Center